Discovery of Novel Antischistosomal Agents by Molecular Modeling Approaches.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Trends in Parasitology

• Publication date

  2016-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.pt.2016.08.002PMID 27593339
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis.

  2016cited by this paper
• Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni

  2016cited by this paper
• Molecular docking to explore the possible binding mode of potential inhibitors of thioredoxin glutathione reductase

  2015cited by this paper
• Quantitative structure–activity relationship: promising advances in drug discovery platforms

  2015cited by this paper
• Target-based molecular modeling strategies for schistosomiasis drug discovery.

  2015cited by this paper
• Machine-learning approaches in drug discovery: methods and applications.

  2015cited by this paper
• Prolyl Oligopeptidase from the Blood Fluke Schistosoma mansoni: From Functional Analysis to Anti-schistosomal Inhibitors

  2015cited by this paper
• Estrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer.

  2015cited by this paper
• Schistosomiasis and its treatment.

  2015cited by this paper
• In Silico Repositioning-Chemogenomics Strategy Identifies New Drugs with Potential Activity against Multiple Life Stages of Schistosoma mansoni

  2015cited by this paper
• Exploring conformational search protocols for ligand-based virtual screening and 3-D QSAR modeling

  2015cited by this paper
• Molecular Docking and Structure-Based Drug Design Strategies

  2015cited by this paper
• Chemical and Genetic Validation of the Statin Drug Target to Treat the Helminth Disease, Schistosomiasis

  2014cited by this paper
• Computational Methods in Drug Discovery

  2014cited by this paper
• Epigenetic Changes Modulate Schistosome Egg Formation and Are a Novel Target for Reducing Transmission of Schistosomiasis

  2014cited by this paper
• Present-day anthelmintics and perspectives on future new targets

  2014cited by this paper
• Challenges, Applications, and Recent Advances of Protein-Ligand Docking in Structure-Based Drug Design

  2014cited by this paper
• Cheminformatics Models for Inhibitors of Schistosoma mansoni Thioredoxin Glutathione Reductase

  2014cited by this paper
• Molecular basis for the antiparasitic activity of a mercaptoacetamide derivative that inhibits histone deacetylase 8 (HDAC8) from the human pathogen schistosoma mansoni.

  2014cited by this paper
• Human schistosomiasis.

  2014cited by this paper
• Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni

  2013cited by this paper
• Schistosomiasis chemotherapy.

  2013cited by this paper
• Chemical predictive modelling to improve compound quality

  2013cited by this paper
• Aldose reductase from Schistosoma japonicum: crystallization and structure-based inhibitor screening for discovering antischistosomal lead compounds

  2013cited by this paper
• Chemotherapie gegen Schistosomiasis

  2013cited by this paper
• Whole-genome sequence of Schistosoma haematobium

  2012cited by this paper
• Whole Organism High-Content Screening by Label-Free, Image-Based Bayesian Classification for Parasitic Diseases

  2012cited by this paper
• Recent advances in Schistosoma genomics

  2012cited by this paper
• Drug discovery in pharmaceutical industry: productivity challenges and trends.

  2012cited by this paper
• Computer-aided drug design: lead discovery and optimization.

  2012cited by this paper
• Susceptibility or resistance of praziquantel in human schistosomiasis: a review

  2012cited by this paper
• Innovative Partnerships for Drug Discovery against Neglected Diseases

  2011cited by this paper
• Regulation of chromatin by histone modifications

  2011cited by this paper
• The productivity crisis in pharmaceutical R&D

  2011cited by this paper
• GeneDB—an annotation database for pathogens

  2011cited by this paper
• Schistosomiasis: from drug deployment to drug development

  2011cited by this paper
• Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle.

  2010cited by this paper
• A glutathione-specific aldose reductase of Leishmania donovani and its potential implications for methylglyoxal detoxification pathway.

  2009cited by this paper
• Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by Auranofin

  2009cited by this paper
• The Schistosoma japonicum genome reveals features of host–parasite interplay

  2009cited by this paper
• The genome of the blood fluke Schistosoma mansoni

  2009cited by this paper
• Genomic-scale prioritization of drug targets: the TDR Targets database

  2008cited by this paper
• SchistoDB: a Schistosoma mansoni genome resource

  2008cited by this paper
• Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target

  2007cited by this paper

• GNN‐DDAS: Drug discovery for identifying anti‐schistosome small molecules based on graph neural network

  2024cites this paper
• Oral Administration of Kaempferol Isolated from Baccharis Mattogrosensis Enables In Vivo Activity Against Schistosoma Mansoni

  2024cites this paper
• Benzimidazole analogues active against adult Schistosoma mansoni: SAR analyses, In vivo efficacy in mice, and preliminary mechanistic studies as potential inhibitors of hemozoin formation.

  2024cites this paper
• Natural Perylenequinone Compounds as Potent Inhibitors of Schistosoma mansoni Glutathione S-Transferase

  2023cites this paper
• Chemical modulation of Schistosoma mansoni lysine specific demethylase 1 (SmLSD1) induces wide-scale biological and epigenomic changes

  2023cites this paper
• Toward anthelmintic drug candidates for toxocariasis: Challenges and recent developments.

  2023cites this paper
• Targeting SmCB1: Perspectives and Insights to Design Antischistosomal Drugs.

  2023cites this paper
• Therapeutic Potential of Natural Products in the Treatment of Schistosomiasis

  2023cites this paper
• Synthetic hydrazones: In silico studies and in vitro evaluation of the antileishmania potential.

  2023cites this paper
• Neolignans isolated from Saururus cernuus L. (Saururaceae) exhibit efficacy against Schistosoma mansoni

  2022cites this paper
• Pyrazoline derivatives as promising novel antischistosomal agents

  2021cites this paper
• Efficacy of carvacryl acetate in vitro and following oral administration to mice harboring either prepatent or patent Schistosoma mansoni infections

  2021cites this paper
• Anti-schistosomal activities of quinoxaline-containing compounds: From hit identification to lead optimisation

  2021cites this paper
• Prediction of antischistosomal small molecules using machine learning in the era of big data

  2021cites this paper
• Licarin A, a neolignan isolated from Nectandra oppositifolia Nees & Mart. (Lauraceae), exhibited moderate preclinical efficacy against Schistosoma mansoni infection

  2021cites this paper
• Antiparasitic Properties of Cardiovascular Agents against Human Intravascular Parasite Schistosoma mansoni

  2021cites this paper
• Synthesis and therapeutic delivery approaches for praziquantel: a patent review (2010-present)

  2021cites this paper
• Antiparasitic activity of piplartine (piperlongumine) in a mouse model of schistosomiasis.

  2020cites this paper
• Schistosoma mansoni sarco/endoplasmic reticulum Ca2+ ATPases (SERCA): role in reduced sensitivity to praziquantel

  2020cites this paper
• Therapeutic Effect of Diminazene Aceturate on Parasitic Blood Fluke Schistosoma mansoni Infection

  2020cites this paper
• Identification of 6-(piperazin-1-yl)-1,3,5-triazine as a chemical scaffold with broad anti-schistosomal activities

  2020cites this paper
• Schistosoma mansoni lysine specific demethylase 1 (SmLSD1) is a druggable target involved in parasite survival, oviposition and stem cell proliferation

  2020cites this paper
• 15β-Senecioyl-oxy-ent-kaur-16-en-19-oic Acid, a Diterpene Isolated from Baccharis lateralis, as Promising Oral Compound for the Treatment of Schistosomiasis.

  2020cites this paper
• H1-antihistamines as antischistosomal drugs: in vitro and in vivo studies

  2020cites this paper
• Vanillin-Related N-Acylhydrazones: Synthesis, Antischistosomal Properties and Target Fishing Studies.

  2019cites this paper
• Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis

  2019cites this paper
• Cytotoxic and Schistosomidal Activities of Extract, Fractions and Isolated Compounds from Zanthoxylum Leprieurii (Rutaceae)

  2019cites this paper
• Discovery of novel Schistosoma mansoni PDE4A inhibitors as potential agents against schistosomiasis.

  2019cites this paper
• Promethazine Exhibits Antiparasitic Properties In Vitro and Reduces Worm Burden, Egg Production, Hepatomegaly, and Splenomegaly in a Schistosomiasis Animal Model

  2019cites this paper
• Drug Discovery and Development for Schistosomiasis

  2019cites this paper
• Discovery of novel Schistosoma mansoni phosphodiesterase 4A inhibitors as potential agents against schistosomiasis

  2019cites this paper
• Schistosomiasis

  2018cites this paper
• From Medicinal Chemistry to Human Health: Current Approaches to Drug Discovery for Cancer and Neglected Tropical Diseases.

  2018cites this paper
• Self-nanoemulsifying drug-delivery systems improve oral absorption and antischistosomal activity of epiisopiloturine.

  2018cites this paper
• Continuous Evaluation of Ligand Protein Predictions: A Weekly Community Challenge for Drug Docking

  2018cites this paper
• In Vitro and In Vivo Studies of Spironolactone as an Antischistosomal Drug Capable of Clinical Repurposing

  2018cites this paper
• Meet Our Regional Editor

  2018cites this paper
• Docking Studies on Novel Analogues of 8-Chloro-Lucia Pintilie and Amalia

  2018cites this paper
• Docking Studies on Novel Analogues of 8-Chloro-Quinolones against Staphylococcus aureus

  2018cites this paper
• Antischistosomal agents: state of art and perspectives.

  2018cites this paper
• Targeting thioredoxin glutathione reductase as a potential antischistosomal drug target.

  2018cites this paper
• Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures.

  2018cites this paper
• Computational quantum chemistry, molecular docking, and ADMET predictions of imidazole alkaloids of Pilocarpus microphyllus with schistosomicidal properties

  2018cites this paper
• Structure–Activity Relationship of Piplartine and Synthetic Analogues against Schistosoma mansoni and Cytotoxicity to Mammalian Cells

  2018cites this paper
• Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as "Doorstop" for NADPH Entry.

  2018cites this paper
• Antiparasitic, structural, pharmacokinetic, and toxicological properties of riparin derivatives.

  2018cites this paper
• Synergistic effects of in vitro combinations of piplartine, epiisopiloturine and praziquantel against Schistosoma mansoni.

  2017cites this paper
• Parasitación de Cornu aspersum Müller, 1774 (Helicidae) por metacercarias del género Brachylaima sensu lato Dujardin, 1843 (Brachylaimidae): tratamiento antihelmíntico y consumo humano

  2017cites this paper
• Cyclohexene-fused 1,3-oxazines with selective antibacterial and antiparasitic action and low cytotoxic effects.

  2017cites this paper